Insider Transactions in Q2 2022 at Hanover Insurance Group, Inc. (THG)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 24
2022
|
Warren E. Barnes SVP & Princpl. Accntg. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.26%
|
-
|
|
Jun 24
2022
|
Jeffrey M Farber Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
50
+0.06%
|
-
|
|
Jun 24
2022
|
Dennis Francis Kerrigan Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.48%
|
-
|
|
Jun 24
2022
|
Richard W Lavey Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
24
+0.08%
|
-
|
|
Jun 24
2022
|
Willard T Lee Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.36%
|
-
|
|
Jun 24
2022
|
Denise Lowsley Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.46%
|
-
|
|
Jun 24
2022
|
John C Roche President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
109
+0.15%
|
-
|
|
Jun 24
2022
|
Bryan J Salvatore Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
21
+0.12%
|
-
|
|
Jun 24
2022
|
Mark Joseph Welzenbach Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
15
+0.07%
|
-
|
|
Jun 13
2022
|
Francisco Aristeguieta Director |
BUY
Grant, award, or other acquisition
|
Direct |
868
+50.0%
|
-
|
|
May 17
2022
|
Jeffrey M Farber Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
39,575
-33.64%
|
$5,857,100
$148.76 P/Share
|
|
May 17
2022
|
Jeffrey M Farber Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
47,510
+28.77%
|
$4,941,040
$104.11 P/Share
|
|
May 10
2022
|
Cynthia Egan Director |
BUY
Grant, award, or other acquisition
|
Direct |
946
+8.34%
|
-
|
|
May 10
2022
|
Harriett Tee Taggart Director |
BUY
Grant, award, or other acquisition
|
Direct |
946
+6.09%
|
-
|
|
May 10
2022
|
Joseph R Ramrath Director |
BUY
Grant, award, or other acquisition
|
Direct |
946
+3.09%
|
-
|
|
May 10
2022
|
Kathy S Lane Director |
BUY
Grant, award, or other acquisition
|
Indirect |
946
+21.7%
|
-
|
|
May 10
2022
|
Wendell J Knox Director |
BUY
Grant, award, or other acquisition
|
Indirect |
946
+21.7%
|
-
|
|
May 10
2022
|
Martin P Hughes Director |
BUY
Grant, award, or other acquisition
|
Direct |
946
+16.34%
|
-
|
|
May 10
2022
|
J Paul Condrin Director |
BUY
Grant, award, or other acquisition
|
Direct |
946
+30.39%
|
-
|
|
May 10
2022
|
Jane D Carlin Director |
BUY
Grant, award, or other acquisition
|
Direct |
946
+50.0%
|
-
|
|
May 10
2022
|
Theodore H Bunting Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
946
+24.95%
|
-
|
|
May 10
2022
|
Kevin Bradicich Director |
BUY
Grant, award, or other acquisition
|
Direct |
946
+13.8%
|
-
|
|
Apr 21
2022
|
John C Roche President and CEO |
SELL
Open market or private sale
|
Direct |
922
-1.22%
|
$142,910
$155.24 P/Share
|
|
Apr 21
2022
|
John C Roche President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
922
+1.2%
|
$36,880
$40.01 P/Share
|